dronabinol has been researched along with Breast Cancer in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aramaki, H; Hirao-Suzuki, M; Takeda, S; Watanabe, K | 1 |
| Beukes, N; Frost, C; Schoeman, R | 1 |
| Andradas, C; Arribas, J; Bernadó-Morales, C; Bibic, L; Blasco-Benito, S; Caffarel, MM; Canals, M; Canela, EI; Caro-Villalobos, M; Casadó, V; Diez-Alarcia, R; Guzmán, M; Hernández, L; Homar-Ruano, P; Manso, L; McCormick, PJ; Moreno, E; Moreno-Bueno, G; Pérez-Gómez, E; Sánchez, C; Seijo-Vila, M; Tundidor, I; Urigüen, L | 1 |
| Amamoto, T; Aramaki, H; Harada, M; Miyoshi, H; Nishimura, H; Okajima, S; Okamoto, Y; Omiecinski, CJ; Su, S; Takeda, S; Watanabe, K; Yoshida, K | 1 |
| Gorter, RW | 1 |
| Andradas, C; Blasco-Benito, S; Caffarel, MM; Canela, EI; Fernández-Ruiz, J; Gómez-Cañas, M; Guzmán, M; Irving, AJ; Lluís, C; McCormick, PJ; Medrano, M; Moreno, E; Pazos, MR; Pérez-Gómez, E; Sánchez, C | 1 |
| Aramaki, H; Harada, M; Himeno, T; Ikeda, E; Ishii, H; Kakizoe, K; Nishimura, H; Okazaki, H; Omiecinski, CJ; Su, S; Takeda, S; Taniguchi, A; Tokuyasu, M; Watanabe, K; Yoshioka, Y | 1 |
| Takeda, S; Watanabe, K; Yamamoto, I | 1 |
| McKallip, RJ; Nagarkatti, M; Nagarkatti, PS | 1 |
| Colvert, M; Henry-Tillman, RS; Kass, R; Klimberg, VS; Layeeque, R; Mancino, A; Siegel, E | 1 |
| Caffarel, MM; Guzmán, M; Palacios, J; Sánchez, C; Sarrió, D | 1 |
| Daeninck, P; Davis, M; Maida, V; Pergolizzi, J | 1 |
| Caffarel, MM; Cerutti, C; Guzman, M; Mechta-Grigoriou, F; Moreno-Bueno, G; Palacios, J; Sanchez, C | 1 |
| Howlett, AC; Ruh, MF; Taylor, JA; Welshons, WV | 1 |
1 review(s) available for dronabinol and Breast Cancer
| Article | Year |
|---|---|
The emerging role of cannabinoid neuromodulators in symptom management.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Dronabinol; Female; Humans; Middle Aged; Pain; Receptors, Cannabinoid; Spinal Neoplasms; Vomiting | 2007 |
13 other study(ies) available for dronabinol and Breast Cancer
| Article | Year |
|---|---|
Δ
Topics: Breast Neoplasms; Cell Movement; Dronabinol; Estrogens; Estrone; Female; Humans; MCF-7 Cells; Receptors, Estrogen | 2023 |
Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Cannabidiol; Cannabinoids; Cell Cycle; Cell Line, Tumor; Cytoplasm; Dronabinol; Endoplasmic Reticulum Chaperone BiP; Female; Humans; Lipid Droplets; MCF-7 Cells; Vacuoles | 2020 |
Therapeutic targeting of HER2-CB
Topics: Breast Neoplasms; Cell Line, Tumor; Dronabinol; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Protein Multimerization; Proto-Oncogene Proteins c-cbl; Receptor, Cannabinoid, CB2; Receptor, ErbB-2; Signal Transduction | 2019 |
Induction of the fatty acid 2-hydroxylase (FA2H) gene by Δ(9)-tetrahydrocannabinol in human breast cancer cells.
Topics: Breast Neoplasms; Cell Differentiation; Dronabinol; Female; Humans; Mixed Function Oxygenases; Oligonucleotide Array Sequence Analysis; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured; Up-Regulation | 2013 |
[Experiences with dronabinol (delta-tetrahydrocannabinol) in oncological patients with anorexia-cachexia syndrome. Illustration of clinical problems and therapy based on 2 case reports].
Topics: Affect; Aged; Analgesics, Non-Narcotic; Anorexia; Bone Neoplasms; Breast Neoplasms; Cachexia; Chronic Pain; Combined Modality Therapy; Dronabinol; Drug Substitution; Drug Therapy, Combination; Female; Humans; Male; Narcotics; Palliative Care; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Quality of Life | 2004 |
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
Topics: Animals; Breast Neoplasms; Cannabinoids; Cell Line, Tumor; Dronabinol; Female; Gene Targeting; Glioblastoma; HEK293 Cells; Humans; Male; Mice; Mice, Nude; Neoplasms; Protein Structure, Quaternary; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Recombinant Proteins; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Δ(9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Dronabinol; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Mixed Function Oxygenases; PPAR alpha; Signal Transduction; Time Factors; Transcription, Genetic; Transfection; Up-Regulation | 2014 |
Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Topics: Arachidonic Acid; Aromatase; Breast Neoplasms; Cannabis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dronabinol; Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; Signal Transduction | 2009 |
Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cytokines; Dronabinol; Female; Gene Expression; Humans; Immune Tolerance; Interleukin-10; Interleukin-4; Lung Neoplasms; Lymphocyte Activation; Mammary Neoplasms, Experimental; Marijuana Smoking; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Neoplasm; Th1 Cells; Th2 Cells | 2005 |
Prevention of nausea and vomiting following breast surgery.
Topics: Administration, Oral; Administration, Rectal; Adult; Antiemetics; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Female; Humans; Logistic Models; Mastectomy; Middle Aged; Multivariate Analysis; Patient Satisfaction; Postoperative Nausea and Vomiting; Preoperative Care; Primary Prevention; Probability; Prochlorperazine; Prognosis; Retrospective Studies; Treatment Outcome | 2006 |
Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Topics: Apoptosis; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Dronabinol; G2 Phase; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger | 2006 |
JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Nucleus; Cell Proliferation; Cell Survival; Disease Progression; Dronabinol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-jun; Tumor Cells, Cultured; Up-Regulation | 2008 |
Failure of cannabinoid compounds to stimulate estrogen receptors.
Topics: Breast Neoplasms; Cannabinoids; Cell Division; Dronabinol; Estrogens; Humans; Phenanthridines; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Transcriptional Activation; Tumor Cells, Cultured | 1997 |